My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$SIAL {{ '2015-11-20T17:20:14+0000' | timeago}} • SEC

$SIAL's research and development expenses for 3Q15 rose slightly by $1MM from 3Q14, as result of inclusion of R&D resulting from purchase of Cell Marque and higher spending on various R&D programs. R&D expenses relate primarily to efforts to add new manufactured products, create and develop new technologies and enhance manufacturing processes.

User Bob Phil {{ '2016-12-08T15:14:43+0000' | timeago}}

$CIEN a good stock to look at for the longs. Consistent revenue increase over the past few quarters suggest steady improvement in profitability of the company, which bodes well for the future prospect. I’m going to add a few more to my portfolio, anticipating good $$$ gains !

User Don Wolters {{ '2016-12-08T00:51:44+0000' | timeago}}

Shareholder alert..!! Rosen Law Firm has commenced an investigation into potential securities claims of $UHS. Shareholders please visit http://www.rosenlegal.com/cases-1008.html for more info.

User Charles Elliston {{ '2016-12-08T00:03:55+0000' | timeago}}

Can we see "Made in the USA" label on iPhones in the near future? Heard that $AAPL is considering the idea of manufacturing iPhone in America.

User Nora Foster {{ '2016-12-08T00:00:35+0000' | timeago}}

People who are looking for a steady growth stock should take a look at $EME. This stock has never had a significant downfall in the last five years. Comfortably beats consensus target most of the time. Such potential, much wow!

User Amelita Yates {{ '2016-12-07T22:59:16+0000' | timeago}}

Looks like Creative Planning jumped on the bandwagon! Increased its stake by 91% in $EWBC. A lot of companies recently raised their stack too. I smell something’s cooking.

$PBH {{ '2016-12-08T15:54:22+0000' | timeago}} • Announcement

$PBH agreed for sale of the DermoPlast brand to Moberg Pharma AB for $47.6MM in cash plus inventory. The transaction is expected to be completed during December 2016. On an annual basis, $PBH expects the financial impact from the sale of DermoPlast to represent about $12MM in net sales and about $0.06 in EPS.

$CASY {{ '2016-12-08T15:51:15+0000' | timeago}} • Webcast

$CASY's total sales in the grocery and other merchandise category were up 5.5% to $545MM in 2Q17. Same-store sales were up 3.1%. This was short of the annual goal due to a deceleration in customer traffic and a tightening in consumer spending. Total sales across all major areas of the category showed mid to high single digit increases.

$CBT {{ '2016-12-08T15:42:38+0000' | timeago}} • Announcement

$CBT's BoD declared quarterly cash dividend of $0.18 per share on its common stock. The dividend is payable on or about Jan. 30, 2017 to shareholders of record on Dec. 23, 2016.

$VRA {{ '2016-12-08T15:39:38+0000' | timeago}} • Announcement

$VRA entered into 3 additional licensing agreements in areas of home, hosiery, and swim. The company previously announced licensing arrangements for stationery and publishing. $VRA will work with licensing partners in development and final approval of all product designs. This will not have a material impact on its performance for FY17 and FY18.

$SAIC {{ '2016-12-08T15:31:52+0000' | timeago}} • Webcast

$SAIC's newly awarded programs, such as the Amphibious Combat Vehicle and GSA Enterprise Operations, generated revenues of $47MM. US Intelligence Community awarded contracts and task orders of approx. $149MM and Defense Logistics Agency awarded contracts of about $1.4Bil.